BlueRun Ventures ranked top 3 in Cyzone's "2022 Most Admired Early-Stage Investment Firms in China"
With a longer-term perspective, supporting companies on the eve of commercialization milestones.
On September 8, Cyzone officially released its 2022 Most Admired Venture Capital Institutions series rankings. The list uses peer review, a method common in scientific fields, to evaluate investment institutions.
The rankings combined registration data and Ruishou Analysis data for initial screening of candidate institutions, and invited nearly 300 senior investors from outstanding VC firms to vote. Based on each institution's comprehensive performance across investment track record, post-investment services, industry standing, innovation capability, long-termism, talent attraction, and ESG practices, these voters selected the venture capital firms they most admired. The final 2022 China Most Admired Venture Capital Institutions series rankings were determined through aggregated voting results.
In this year's selection, BlueRun Ventures was ranked TOP 3 in the "30 Most Admired Early-Stage Investment Institutions."
As a venture capital firm focused on early-stage startups, BlueRun believes that the most critical value an early-stage investor can provide is working alongside founders at the 0-to-1 phase to identify and address market needs earlier and more precisely, and through a longer-term perspective, supporting companies still on the verge of commercial inflection points. Only by daring to go first can one embrace an undefined future.
Further Reading
Nine Awards! BlueRun Receives Multiple Honors in 2021-2022 China PE/VC Industry Rankings
BlueRun Ventures' Jui Chan and Terry Zhu Named to ChinaVenture 2021 "China's Best Early-Stage Investors TOP50"
BlueRun Ventures' Jui Chan Named to 2022 "PEDaily TOP100" Investors
BlueRun Ventures was founded in Silicon Valley in 1998. BlueRun Ventures China was established in 2005 as a venture capital firm focused on early-stage startups.
Currently, BlueRun Ventures China manages multiple USD and RMB dual-currency funds with over RMB 15 billion in assets under management, making it one of the largest early-stage funds in China. It focuses on Pre-A and Series A investments across hard tech and innovative interaction, enterprise technology, new consumer, and healthcare sectors. The firm has invested in over 150 startups, including Li Auto, Waterdrop, QingCloud, Guazi Used Car, Qudian, Songguo Mobility, Ganji.com, Energy Monster, Yuntou Semiconductor, Machenike, CloudSaints, Anxinnet, and BioMap.
BlueRun Ventures has previously been ranked #1 in Zero2IPO's "China Early-Stage Investment Institutions 30" and ChinaVenture's "China Best Early-Stage Venture Capital Institutions TOP30," and was named to Preqin's Global Top 10 VC Fund Managers for Sustained High Returns.
Additionally, BlueRun Ventures has received consecutive annual honors from media organizations including Forbes China, 36Kr, Cyzone, Caixin Media, CBNweekly, and Jiemian, including "China's Best Early-Stage Institution of the Year," "China's Top Venture Capital Firm," "Most Founder-Friendly Early-Stage Institution of the Year," and "Most Influential Early-Stage Institution of the Year."